Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,234 total articles
Anavex Life Sciences highlights research uncovering shared biological pathways between autism spectrum disorder (ASD) and Alzheimer's disease (AD), particularly impaired autophagy and synaptic dysfunction. These discoveries validate the scientific rationale for advancing their oral drug candidate blarcamesine, which activates SIGMAR1 to restore cel…
Praxis Precision Medicines announced that the FDA has accepted for review the New Drug Application for ulixacaltamide HCl to treat essential tremor in adults. The FDA set a PDUFA target action date of January 29, 2027, and no advisory committee meeting is planned. The NDA is supported by positive Phase 3 Essential3 trial results showing efficacy an…
FirstService Corporation has completed two tuck-under acquisitions, adding company-owned operations to its Paul Davis Restoration and California Closets business lines in key Midwest U.S. markets. The acquisitions include Paul Davis Restoration's franchised operations in Cleveland and Akron, Ohio, and California Closets' franchised territories cove…
XCHG Limited, an integrated EV charging and energy solutions company dual-headquartered in Hamburg and Austin, will participate in the Webull Corporate Connect Webinar Series focused on the Clean Energy Sector. Executives Joel A. Gallo and Aatish Patel will discuss the company's financial performance and deployment strategies for high-power EV char…
Toll Brothers, Inc. (NYSE:TOL), a leading luxury home builder, has opened its newest community, Toll Brothers at Midline, in Webster, Texas. The development features 25 spacious single-family homes with high-end amenities and proximity to top-rated schools and convenience, targeting luxury homebuyers in the Houston area.
Galera Therapeutics and Obsidian Therapeutics announced a definitive all-stock merger to form Obsidian Therapeutics, Inc., and secured an oversubscribed $350 million private placement. The combined company will focus on advancing Obsidian's lead product OBX-115, an engineered tumor infiltrating lymphocyte (TIL) therapy in Phase 2 and Phase 1 trials…
The E.W. Scripps Company will release its first-quarter 2026 operating results on May 7, 2026, after market close. A conference call with senior management will follow on May 8, providing investors and analysts an opportunity to discuss the company's performance. Scripps is a leading diversified U.S. media company operating approximately 60 TV stat…
Microbot Medical Inc., a Nasdaq-listed medical device company, showcased its recent commercial achievements leading to the full market release of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference. The LIBERTY system is the first FDA-cleared, single-use, remotely operated robotic system designed for pe…
Cricut, Inc. has launched AI Project Designer, a new AI-powered tool integrated within Cricut Design Space that allows users to create personalized, ready-to-make 2D designs by describing their project ideas in natural language. This tool enhances the user experience by simplifying design creation and editing via a conversational interface and supp…
Teva Pharmaceutical Industries Ltd., along with Direct Relief and NAFC, has announced a second round of grant funding totaling $75,000 each to 11 free and charitable clinics across Alabama, Mississippi, and Texas. This funding supports expansions in mental health services, including counseling, telehealth, and outreach, aiming to improve access and…
AVITA Medical announced positive interim results from its Cohealyx-I multi-center study demonstrating a significant reduction in mean time to skin grafting—from 33.2 days benchmark down to 13.6 days—for patients with full-thickness wounds. The study results indicate faster wound bed preparation and higher investigator satisfaction, which may suppor…
Toll Brothers, a leading U.S. luxury homebuilder, is launching Cambric Village in Greenville, South Carolina, featuring 13 luxury single-family homes available from summer 2026 and townhomes in spring 2027. The development highlights upscale designs, prime location, and personalized home options, supporting Toll Brothers' growth in the luxury resid…
Our Bond, Inc. announced that four new international cities are adopting its AI-powered Preventative Personal Security platform, substantially growing its government-to-consumer channel. Recognized as a sole supplier after an independent security review, Bond expects significant recurring revenue from these partnerships. The expansion across enterp…
Eldorado Gold Corporation has completed its acquisition of Foran Mining Corporation, gaining full ownership of the McIlvenna Bay Project, a significant copper-zinc-gold-silver deposit in Canada. This acquisition diversifies Eldorado's asset base with a long-life, high-quality copper asset in a premier mining jurisdiction. Eldorado plans to delist F…
Toll Brothers, a leading luxury home builder listed on NYSE as TOL, announced the grand opening of two new model homes at its Ladera Trails community in San Tan Valley, Arizona. Featuring spacious designs, upscale finishes, and resort-style amenities, the community offers luxury desert living with expansive home sites starting in the mid-$800,000s.…
Smithfield Foods introduces Meal Ready Cuts, a new line of pre-cut, pre-marinated fresh pork products designed to deliver bold, globally inspired flavors in under 20 minutes without any preparation. Available nationwide, these products cater to consumers seeking convenient, high-protein meal solutions with minimal effort. The launch supports Smithf…
Rent the Runway, Inc. reported financial results for fiscal year 2025 ending January 31, 2026, highlighting a 20% increase in active subscribers and 20% revenue growth in Q4, reaching a record $91.7 million quarterly revenue. The company improved its balance sheet, inventory, customer satisfaction, and introduced an AI-powered discovery platform an…
SurgePays, Inc. announced its full-year 2025 financial and operational results, highlighting scalable growth in its prepaid wireless and fintech services while significantly reducing operating costs. The company diversified revenue streams post the Affordable Connectivity Program, growing its subscriber base and launching new monetization initiativ…
Geron Corporation awarded a stock option grant of 2.5 million shares to Timothy Williams, their new Executive Vice President, Chief Legal Officer, and Corporate Secretary, as an inducement for joining the company. The options have a 10-year term, an exercise price equal to the closing stock price on the grant date, and vest over four years. This gr…
Structure Therapeutics Inc., a clinical-stage biopharmaceutical company focused on novel oral small molecule therapeutics for metabolic diseases, has appointed Matthew Lang, J.D. as Chief Operating Officer and General Counsel. Lang brings extensive experience in global biopharma leadership, legal, corporate strategy, and commercialization, supporti…
Cricut, Inc., a creative technology company known for its smart cutting machines and related products, will announce its financial results for the first quarter ended March 31, 2026, after U.S. markets close on May 5, 2026. Management will hold an earnings conference call and webcast to discuss the results.
EverQuote, Inc., an online insurance marketplace, announced it will report its first quarter 2026 financial results after market close on May 4, 2026, followed by a management conference call and webcast to discuss results and business outlook.
Aligos Therapeutics reported favorable interim results from its Phase 2 B-SUPREME study investigating pevifoscorvir sodium in chronic hepatitis B virus (HBV) patients. The independent Data Safety Monitoring Board recommended continuing the study with increased sample size, and futility criteria were not met. Additionally, pevifoscorvir sodium recei…
Cellectar Biosciences has initiated the Phase 1b clinical trial for CLR 125, an Auger-emitting radioconjugate designed to treat relapsed or refractory triple negative breast cancer (TNBC). This trial marks a key milestone in developing targeted therapies for TNBC, a subtype with limited treatment options. CLR 125 leverages the company's proprietary…
CNB Financial Corporation announced a quarterly cash dividend of $0.4453125 per depositary share, stemming from a dividend of $17.8125 per share on its Series A Preferred Stock, payable June 1, 2026. The company, a financial holding firm with approximately $8.4 billion in assets, operates primarily through CNB Bank, offering a broad range of bankin…
